| MAY 2026 | APR 2026 | MAR 2026 | FEB 2026 | JAN 2026 | DEC 2025 | |
|---|---|---|---|---|---|---|
| Number of Holdings | 23 | 26 | 26 | 26 | 27 | 27 |
| Top 5 Company Holdings | 36.8% | 34.13% | 35.58% | 34.64% | 32.75% | 33.05% |
| Top 10 Company Holdings | 58.35% | 55.72% | 55.43% | 54.7% | 53.07% | 54.7% |
| Company with Highest Exposure | Sun Pharmaceutical Industries (10.61%) | Sun Pharmaceutical Industries (11.22%) | Sun Pharmaceutical Industries (11.77%) | Sun Pharmaceutical Industries (11.09%) | Sun Pharmaceutical Industries (10.64%) | Sun Pharmaceutical Industries (10.85%) |
| Number of Sectors | 2 | 2 | 2 | 2 | 2 | 2 |
| Top 3 Sector Holdings | 92.92% | 96.12% | 96.18% | 96.23% | 95.49% | 98.01% |
| Top 5 Sector Holdings | 92.92% | 96.12% | 96.18% | 96.23% | 95.49% | 98.01% |
| Sector with Highest Exposure | Healthcare (87.54%) | Healthcare (91.43%) | Healthcare (91.46%) | Healthcare (91.53%) | Healthcare (90.6%) | Healthcare (93.41%) |
(Scheme Rating)
LIC MF Healthcare Fund Direct - Growth
NAV as of Jun 10, 2026
33.97-0.26%
(Earn upto 1.31% Extra Returns with Direct Plan)
Investment Growth
LIC MF Healthcare Fund Direct - Growth Fund Details
Investment Objective - The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
| Fund House | LIC Mutual Fund |
| Launch Date | Feb 28, 2019 |
| Benchmark | BSE Healthcare Total Return Index |
| Return Since Launch | 18.28% |
| Riskometer | Very High |
| Fund Category | Equity: Sectoral-Pharma |
| Expense Ratio | 1.13%(0.97% Category average) |
| Fund Size | Rs. 88.96 Cr(0.25% of Investment in Category) |
| Type | Open-ended |
| Risk Grade | Above Average |
| Return Grade | Below Average |
LIC MF Healthcare Fund Direct - Growth Investment Details
| Minimum Investment (Rs.) | 5,000.00 |
| Minimum Additional Investment (Rs.) | 500.00 |
| Minimum SIP Investment (Rs.) | 200.00 |
| Minimum Withdrawal (Rs.) | 1,000.00 |
| Exit Load Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | |
1. Current NAV: The Current Net Asset Value of the LIC MF Healthcare Fund - Direct Plan as of Jun 10, 2026 is Rs 33.97 for Growth option of its Direct plan.
2. Returns: Its trailing returns over different time periods are: 10.37% (1yr), 24.3% (3yr), 12.12% (5yr) and 18.3% (since launch). Whereas, Category returns for the same time duration are: 11.02% (1yr), 23.79% (3yr) and 13.59% (5yr).
3. Fund Size: The LIC MF Healthcare Fund - Direct Plan currently holds Assets under Management worth of Rs 84.53 crore as on Apr 30, 2026.
4. Expense ratio: The expense ratio of the fund is 1.13% for Direct plan as on May 29, 2026.
5. Exit Load: LIC MF Healthcare Fund - Direct Plan shall attract an Exit Load, "Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days."
6. Minimum Investment: Minimum investment required is Rs 5000 and minimum additional investment is Rs 500. Minimum SIP investment is Rs 200.
LIC MF Healthcare Fund Direct - Growth Returns
Trailing Returns
Rolling Returns
Discrete Period
SIP Returns
1M 3M 6M 1Y 3Y 5Y Annualized Returns -0.22 7.51 6.53 8.35 23.58 11.70 Category Avg 0.95 6.76 7.63 9.21 23.16 13.19 Rank within Category 22 14 17 15 8 10 No. of funds within Category 33 33 30 27 17 12
Return Comparison
- BenchmarkS&P BSE Sensex
- Stock, MF & Index
Choose from Benchmarks
- Nifty 50
- NAV:--
- S&P BSE Sensex:--
- 1M
- 3M
- 6M
- 1Y
- 5Y
Portfolio Allocation
Asset Allocation
Asset Allocation History
Sector Allocation
Market Cap Allocation
Concentration & Valuation Analysis
Top Stock Holdings
Sector Holdings in MF
Company Sector Assest(%) P/E EPS-TTM(₹) RETURN 1 YR(%) Sun Pharmaceutical Industries Healthcare 11.22 - - - Apollo Hospitals Enterprise Healthcare 6.52 - - - Torrent Pharmaceuticals Healthcare 6.5 - - - Aurobindo Pharma Healthcare 5.15 - - - Divi's Laboratories Healthcare 4.74 - - - Fortis Healthcare Healthcare 4.7 - - - Neuland Laboratories Healthcare 4.59 - - - Onesource Specialty Pharma Healthcare 4.56 - - - Piramal Pharma Healthcare 4.33 - - - Glenmark Pharmaceuticals Healthcare 3.41 - - -
Peer Comparison
Cumulative Returns
SIP returns
Discrete Returns
Quant Measures
Asset Allocation
Scheme Name NAV(Rs./Unit) Scheme Rating AUM(Rs. Cr) 1M 1Y 3Y 5Y LIC MF Healthcare Fund Direct - Growth 33.97 88.96 -0.91 8.20 23.65 11.59 SBI Healthcare Opportunities Fund Direct Plan-Growth 540.87 4,565.95 2.42 11.02 26.10 16.65 UTI Healthcare Fund Direct-Growth 352.56 1,216.85 1.96 10.39 27.37 14.92 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth 44.62 6,453.52 -0.84 5.18 27.43 15.98 Nippon India Pharma Fund Direct-Growth 600.43 8,635.75 -0.43 5.06 22.99 13.23
Risk Ratios
Ratios are calculated using the calendar month returns for the last 3 years
Standard Deviation
High Volatality
16.35VS16.03Fund Vs Category Avg
Beta
High Volatality
0.93VS0.91Fund Vs Category Avg
Sharpe Ratio
Poor risk-adjusted returns
1.06VS1.11Fund Vs Category Avg
Treynor's Ratio
Poor risk-adjusted returns
18.65VS19.60Fund Vs Category Avg
Jensen's Alpha
Poor risk-adjusted returns
-0.38VS0.43Fund Vs Category Avg
Mean Return
Poor average monthly returns
23.21VS23.66Fund Vs Category Avg
Risk Ratio Chart
- Risk Ratio
- Category Average
LIC Mutual Fund News
- Indian market poised for double-digit earnings growth over next 2 years: Dikshit Mittal

- NFO Insight: Will TIDE investment strategy of this tech mutual fund help you navigate market volatility?

- Mutual fund NFO: Only one fund will open for subscription this week. Check details

- LIC Mutual Fund announces launch of India’s first women-centric AMC branch

Fund Manager
- P.P.Puneet PalSince Apr 2023
- V.P.Vinay PahariaSince Apr 2023
- V.S.Vivek SharmaSince Apr 2024
- U.M.Utsav MehtaSince Apr 2024
Mr. Pal is a B.Com (H) and MBA from SIBM Pune. Prior to joining PGIM India Mutual Fund, he has worked with BNP Paribas AMC as Head Fixed Income, UTI AMC as Sr. Vice President & Fund Manager & TATA AMC as Fund Manager.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y PGIM India Gilt Direct Plan-IDCW Quarterly Gilt 14.23 92.58 0.86 PGIM India Flexi Cap Fund Direct-IDCW Flexi Cap 19.34 5,732.98 -3.06 PGIM India Aggressive Hybrid Equity Fund Direct-IDCW Aggressive Hybrid 23.88 201.84 -2.62 PGIM India Midcap Fund Direct-IDCW Mid Cap 60.21 10,821.62 -3.18 PGIM India Arbitrage Fund Direct-IDCW Arbitrage 12.36 92.17 6.18 PGIM India Balanced Advantage Fund Direct-IDCW Dynamic Asset Allocation 10.52 797.63 -3.68 PGIM India Multi Asset Allocation Fund Direct - IDCW Multi Asset Allocation 10.18 Unrated 273.65 - PGIM India Healthcare Fund Direct-IDCW Sectoral-Pharma 11.10 Unrated 95.49 12.69 PGIM India Multi Cap Fund Direct-IDCW Multi Cap 10.06 Unrated 413.64 2.65 PGIM India Retirement Fund Direct - IDCW Multi Cap 11.92 Unrated 98.56 -3.01 PGIM India Large and Mid Cap Fund Direct - IDCW Large & MidCap 11.11 Unrated 781.86 -4.00 PGIM India CRISIL IBX Gilt Index - Apr 2028 Fund Direct - IDCW Target Maturity 10.51 Unrated 21.62 4.69 Mr. Paharia holds a B.Com degree from Narsee Monjee College and an M.M.S. degree from Welingkar Institute of Management, Mumbai. Prior to joining PGIM India Mutual Fund, he was associated with Union Mutual Fund, Invesco Asset Management Company, L&T Mutual Fund, K R Choksey Shares and Securities Pvt Ltd (Jan 2004-Jan 2006), First Global Stock broking Pvt. Ltd (Jun 2002-Jan 2004).
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y PGIM India ELSS Tax Saver Fund Direct-IDCW ELSS 16.68 688.59 -5.81 PGIM India Balanced Advantage Fund Direct-IDCW Dynamic Asset Allocation 10.52 797.63 -3.68 PGIM India Aggressive Hybrid Equity Fund Direct-IDCW Aggressive Hybrid 23.88 201.84 -2.62 PGIM India Large Cap Fund Direct-IDCW Large Cap 25.61 534.93 -5.76 PGIM India Flexi Cap Fund Direct-IDCW Flexi Cap 19.34 5,732.98 -3.06 PGIM India Midcap Fund Direct-IDCW Mid Cap 60.21 10,821.62 -3.18 PGIM India Retirement Fund Direct - IDCW Multi Cap 11.92 Unrated 98.56 -3.01 PGIM India Large and Mid Cap Fund Direct - IDCW Large & MidCap 11.11 Unrated 781.86 -4.00 Mr. Sharma is a PGDM Finance Prior to joining PGIM India Asset Management Pvt. Ltd. - Equity Analyst and Asst. Fund Manager, he has worked with ICICI Securities Ltd. - Equity Analyst and JP Morgan Services India Pvt. Ltd.- Associate - Investment Banking.
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y PGIM India ELSS Tax Saver Fund Direct-IDCW ELSS 16.68 688.59 -5.81 PGIM India Midcap Fund Direct-IDCW Mid Cap 60.21 10,821.62 -3.18 PGIM India Aggressive Hybrid Equity Fund Direct-IDCW Aggressive Hybrid 23.88 201.84 -2.62 PGIM India Large Cap Fund Direct-IDCW Large Cap 25.61 534.93 -5.76 PGIM India Flexi Cap Fund Direct-IDCW Flexi Cap 19.34 5,732.98 -3.06 PGIM India Multi Asset Allocation Fund Direct - IDCW Multi Asset Allocation 10.18 Unrated 273.65 - PGIM India Healthcare Fund Direct-IDCW Sectoral-Pharma 11.10 Unrated 95.49 12.69 PGIM India Multi Cap Fund Direct-IDCW Multi Cap 10.06 Unrated 413.64 2.65 PGIM India Retirement Fund Direct - IDCW Multi Cap 11.92 Unrated 98.56 -3.01 Mr. Mehta has done B.Com and CFA Prior to joining PGIM Mutual Fund, he has worked with Edelweiss Asset Management Ltd and Ambit Capital
Scheme Name Category Nav(Rs./Unit) Scheme Rating Asset(Rs. Cr) 1Y PGIM India Balanced Advantage Fund Direct-IDCW Dynamic Asset Allocation 10.52 797.63 -3.68 PGIM India ELSS Tax Saver Fund Direct-IDCW ELSS 16.68 688.59 -5.81 PGIM India Midcap Fund Direct-IDCW Mid Cap 60.21 10,821.62 -3.18 PGIM India Multi Asset Allocation Fund Direct - IDCW Multi Asset Allocation 10.18 Unrated 273.65 - PGIM India Healthcare Fund Direct-IDCW Sectoral-Pharma 11.10 Unrated 95.49 12.69 PGIM India Multi Cap Fund Direct-IDCW Multi Cap 10.06 Unrated 413.64 2.65 PGIM India Large and Mid Cap Fund Direct - IDCW Large & MidCap 11.11 Unrated 781.86 -4.00
More LIC Mutual Fund
| Scheme Name | Rating | Asset Size(Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| LIC MF Liquid Fund Direct-Growth | 16,014.85 | 0.54 | 1.75 | 3.24 | 6.24 | 6.95 | |
| LIC MF Money Market Fund Direct - Growth | 4,897.66 | 0.54 | 1.64 | 3.04 | 6.21 | 6.70 | |
| LIC MF Large & Mid Cap Fund Direct-Growth | 2,958.49 | -4.47 | -1.83 | -4.37 | -6.83 | 15.29 | |
| LIC MF Multi Cap Fund Direct - Growth | 1,849.35 | -1.98 | 4.61 | 1.12 | 1.57 | 19.50 | |
| LIC MF Banking & PSU Fund Direct-Growth | 1,831.19 | 0.80 | 1.43 | 2.36 | 4.61 | 7.27 | |
| LIC MF Low Duration Fund Direct-Growth | 1,607.70 | 0.63 | 1.65 | 3.00 | 6.16 | 7.33 | |
| LIC MF Large Cap Fund Direct-Growth | 1,352.11 | -3.98 | -3.87 | -9.64 | -9.61 | 8.40 | |
| LIC MF Overnight Fund Direct - Growth | 1,212.21 | 0.44 | 1.31 | 2.58 | 5.35 | 6.21 | |
| LIC MF Infrastructure Fund Direct-Growth | 1,046.65 | -2.17 | 7.03 | 9.62 | 4.73 | 27.63 | |
| LIC MF ELSS Tax Saver Direct - Growth | 993.77 | -3.37 | -1.88 | -7.00 | -8.45 | 10.70 |
Mutual Fund Tools
Top AMCs
Fund For AMC data not available for this fund
FAQs about LIC MF Healthcare Fund Direct - Growth
- Is it safe to invest in LIC MF Healthcare Fund - Direct Plan?As per SEBI’s latest guidelines to calculate risk grades, investment in the LIC MF Healthcare Fund - Direct Plan comes under Very High risk category.
- What is the category of LIC MF Healthcare Fund - Direct Plan?LIC MF Healthcare Fund - Direct Plan belongs to the Equity : Sectoral-Pharma category of funds.
- How Long should I Invest in LIC MF Healthcare Fund - Direct Plan?The suggested investment horizon of investing into LIC MF Healthcare Fund - Direct Plan is >3 years. The suggested investment horizon is the minimum time required for holding investments in the fund to reduce its downside risk and ensure that the returns become more predictable.
- Who manages the LIC MF Healthcare Fund - Direct Plan?The LIC MF Healthcare Fund - Direct Plan is managed by Sudhanshu Asthana (Since Apr 07, 2026).
1. LIC MF Healthcare Fund - Direct Plan is Open-ended Sectoral-Pharma Equity scheme which belongs to LIC Mutual Fund House.
2. The fund was launched on Feb 28, 2019.
Investment objective & Benchmark
1. The investment objective of the fund is that " The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. "
2. It is benchmarked against BSE Healthcare Total Return Index.
Asset Allocation & Portfolio Composition
1. The asset allocation of the fund comprises around 96.12% in equities, 0.0% in debts and 3.88% in cash & cash equivalents.
2. While the top 10 equity holdings constitute around 55.72% of the assets, the top 3 sectors constitute around 96.12% of the assets.
3. The fund largely follows a Growth oriented style of investing and invests across market capitalisations - around 0.0% in giant & large cap companies, 0.0% in mid cap and 0.0% in small cap companies.
Tax Implications on LIC MF Healthcare Fund Direct - Growth
1. Gains are taxed at a rate of 15% (Short-term Capital Gain Tax - STCG) if units are redeemed within 1 year of investment.
2. For units redeemed after 1 year of investment, gains of upto Rs. 1 lakh accruing from those units in a financial year shall be exempted from tax.
3. Gains of more than Rs. 1 lakh will be taxed at a rate of 10% (Long-term Capital Gain Tax - LTCG).
4. For Dividend Distribution Tax, the dividend income from this fund will get added to the income of an investor and taxed according to his/her respective tax slabs.
5. Also, for dividend income in excess of Rs 5,000 in a financial year; the fund house shall deduct a TDS of 10% on such income.